Horenblas S - Search Results

1

The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer.

Powles T, Blank C, Chowdhury S, Horenblas S, Peters J, Shamash J, Sarwar N, Boleti E, Sahdev A, O'Brien T, Berney D, Beltran L, Nathan P, Haanen J, Bex A. Powles T, et al. Among authors: horenblas s. Eur Urol. 2011 Sep;60(3):448-54. doi: 10.1016/j.eururo.2011.05.028. Epub 2011 May 17. Eur Urol. 2011. PMID: 21612860

2

Metastasectomy in renal cell carcinoma: A multicenter retrospective analysis.

van der Poel HG, Roukema JA, Horenblas S, van Geel AN, Debruyne FM. van der Poel HG, et al. Among authors: horenblas s. Eur Urol. 1999;35(3):197-203. doi: 10.1159/000019849. Eur Urol. 1999. PMID: 10072620

3

Controlling gene expression in the urothelium using transgenic mice with inducible bladder specific Cre-lox recombination.

Bex A, Vooijs M, Horenblas S, Berns A. Bex A, et al. Among authors: horenblas s. J Urol. 2002 Dec;168(6):2641-4. doi: 10.1016/S0022-5347(05)64235-8. J Urol. 2002. PMID: 12442001

4

The role of initial immunotherapy as selection for nephrectomy in patients with metastatic renal cell carcinoma and the primary tumor in situ.

Bex A, Horenblas S, Meinhardt W, Verra N, de Gast GC. Bex A, et al. Among authors: horenblas s. Eur Urol. 2002 Dec;42(6):570-4; discussion 575-6. doi: 10.1016/s0302-2838(02)00404-9. Eur Urol. 2002. PMID: 12477652

5

Unusual complication after immediate postoperative intravesical mitomycin C instillation.

Nieuwenhuijzen JA, Bex A, Horenblas S. Nieuwenhuijzen JA, et al. Among authors: horenblas s. Eur Urol. 2003 Jun;43(6):711-2. doi: 10.1016/s0302-2838(03)00151-9. Eur Urol. 2003. PMID: 12767376

6

Immunotherapy with concurrent subcutaneous GM-CSF, low-dose IL-2 and IFN-alpha in patients with progressive metastatic renal cell carcinoma.

Verra N, Jansen R, Groenewegen G, Mallo H, Kersten MJ, Bex A, Vyth-Dreese FA, Sein J, van de Kasteele W, Nooijen WJ, de Waal M, Horenblas S, de Gast GC. Verra N, et al. Among authors: horenblas s. Br J Cancer. 2003 May 6;88(9):1346-51. doi: 10.1038/sj.bjc.6600915. Br J Cancer. 2003. PMID: 12778059 Free PMC article. Clinical Trial.

7

The timing of immunotherapy and nephrectomy in multimodality treatment of metastatic renal cell carcinoma.

Bex A, Horenblas S, de Gast GC. Bex A, et al. Among authors: horenblas s. Technol Cancer Res Treat. 2003 Jun;2(3):205-10. doi: 10.1177/153303460300200304. Technol Cancer Res Treat. 2003. PMID: 12779351 Free article. Review.

8

Port site metastasis after laparoscopic nephro-ureterectomy for transitional cell carcinoma.

Naderi N, Nieuwenhuijzen JA, Bex A, Kooistra A, Horenblas S. Naderi N, et al. Among authors: horenblas s. Eur Urol. 2004 Oct;46(4):440-1. doi: 10.1016/j.eururo.2003.12.018. Eur Urol. 2004. PMID: 15363556 No abstract available.

9

A phase-II study of pegylated interferon alfa-2b for patients with metastatic renal cell carcinoma and removal of the primary tumor.

Bex A, Mallo H, Kerst M, Haanen J, Horenblas S, de Gast GC. Bex A, et al. Among authors: horenblas s. Cancer Immunol Immunother. 2005 Jul;54(7):713-9. doi: 10.1007/s00262-004-0630-9. Epub 2004 Dec 31. Cancer Immunol Immunother. 2005. PMID: 15627213 Free PMC article. Clinical Trial.

10

Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer.

Bex A, Nieuwenhuijzen JA, Kerst M, Pos F, van Boven H, Meinhardt W, Horenblas S. Bex A, et al. Among authors: horenblas s. Urology. 2005 Feb;65(2):295-9. doi: 10.1016/j.urology.2004.09.049. Urology. 2005. PMID: 15708041

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

352 results

Search Page

Filters